advertisement

The global therapeutic scenario for T-cell lymphomas unfolds emerging opportunities

50 %
50 %
advertisement
Information about The global therapeutic scenario for T-cell lymphomas unfolds emerging...
Business & Mgmt

Published on February 27, 2014

Author: researchonglobalmarkets

Source: slideshare.net

Description

For the complete report ,visit us at: http://bit.ly/t-cell-2013

Or, get in touch with us at : support@researchonglobalmarkets.com

Abstract:
T-Cell Lymphomas - Pipeline Review, H2 2013
Summary
Global Markets Directs, 'T-Cell Lymphomas - Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for T-Cell Lymphomas. T-Cell Lymphomas - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for T-Cell Lymphomas.
- A review of the T-Cell Lymphomas products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the T-Cell Lymphomas pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Table of Contents:
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
T-Cell Lymphomas Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for T-Cell Lymphomas 9
T-Cell Lymphomas Therapeutics under Development by Companies 11
T-Cell Lymphomas Therapeutics under Investigation by Universities/Institutes 13
Late Stage Products 14
Comparative Analysis 14
Mid Clinical Stage Products 15
Comparative Analysis 15
Early Clinical Stage Products 16
Comparative Analysis 16
Discovery and Pre-Clinical Stage Products 17
Comparative Analysis 17
advertisement

Report: T-Cell Lymphomas - Pipeline Review, H2 2013 Category: Healthcare Insert Image Height - 3.60 Width – 4.98 www.researchonglobalmarkets.com

Report: T-Cell Lymphomas - Pipeline Review, H2 2013 Report Coverage • A snapshot of the global therapeutic scenario for T-Cell Lymphomas • A review of the T-Cell Lymphomas products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Coverage of products based on various stages of development ranging from discovery till registration stages • A feature on pipeline projects on the basis of monotherapy and combined therapeutics • Coverage of the T-Cell Lymphomas pipeline on the basis of route of administration and molecule type www.researchonglobalmarkets.com

Report: T-Cell Lymphomas - Pipeline Review, H2 2013 Report Coverage (Continued) • All discontinued pipeline projects • Latest news and deals related to the products www.researchonglobalmarkets.com

Report: T-Cell Lymphomas - Pipeline Review, H2 2013 Report Benefits • Identify and understand important and diverse types of therapeutics under development for T-Cell Lymphomas • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding TCell Lymphomas pipeline depth and focus of indication therapeutics www.researchonglobalmarkets.com

Report: T-Cell Lymphomas - Pipeline Review, H2 2013 Report Benefits (Continued) • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline www.researchonglobalmarkets.com

Report: T-Cell Lymphomas - Pipeline Review, H2 2013 Table of Contents • Introduction • Overview • Comparative Analysis • R&D Progress • Appendix • Methodology www.researchonglobalmarkets.com

Report: T-Cell Lymphomas - Pipeline Review, H2 2013 Report Details • • • • • • • • • Publish date: 29th Oct, 2013 Number of slides: 124 Geographic coverage: Global Available format: PDF, CD, Hardcopy Price for Single User License: USD 2,000 Price for Site License: USD 4,000 Price for Global User License: USD 6,000 Delivery Time: Within 1 business day Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal www.researchonglobalmarkets.com

Interested in this report? To view more details regarding this premium market research report, Please click here For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports Industry Segments Automotive & Transport Consumer goods Agriculture Food and Beverage Energy and Utilities Public Sector Manufacturing & Construction Healthcare Media & Entertainment IT, Telecom & Electronics Services Others www.researchonglobalmarkets.com

Add a comment

Related presentations

Canvas Prints at Affordable Prices make you smile.Visit http://www.shopcanvasprint...

30 Días en Bici en Gijón organiza un recorrido por los comercios históricos de la ...

Con el fin de conocer mejor el rol que juega internet en el proceso de compra en E...

With three established projects across the country and seven more in the pipeline,...

Retailing is not a rocket science, neither it's walk-in-the-park. In this presenta...

What is research??

What is research??

April 2, 2014

Explanatory definitions of research in depth...

Related pages

The global therapeutic scenario for T-cell lymphomas ...

Title: The global therapeutic scenario for T-cell lymphomas unfolds emerging opportunities, Author: Research on Global Markets, Name: ...
Read more

The global therapeutic scenario for T-cell lymphomas ...

Report: T-Cell Lymphomas - Pipeline Review, H2 2013 Report Coverage • A snapshot of the global therapeutic scenario for T-Cell Lymphomas • A review of ...
Read more

www.springer.com

Immunotherapy.- Therapeutic strategies and ... Link (Eds.)";Pediatric Lymphomas;;Pediatric Oncology ... Supply Chain Excellence in Emerging ...
Read more

08036Ciesla15264 - Scribd

08036Ciesla15264 - Ebook download as PDF ... These products are used to stimulate a specific cell production to yield therapeutic benefit for the ...
Read more

Hematology in Practice - scribd.com

red cell. These products are used to stimulate a specific cell production to yield therapeutic benefit for the patient.
Read more

12 October 2000 - Universidad Michoacana de San Nicolás ...

An emerging blueprint for ... migratory dendritic cells transport apoptotic intestinal epithelial cells to T-cell areas ... Follicular lymphomas result ...
Read more

Conceptual Glossary of Medical Terms.

Conceptual Glossary of Medical Terms. ... Combinatorial joining allows multiple opportunities for 2 sets of genes to ... (Cytolytic) T cell: ...
Read more

Books by Subject - Lane Medical Library - Stanford ...

Cutaneous T-Cell Lymphoma and ... Molecular subtypes and emerging therapeutic opportunities ... chapters are included on T-cell lymphomas, ...
Read more

www.springer.com

... EGAPP Projects Evaluate Emerging Genetic Tests. 3.5 Assessing ... global experts takes our current ... and interactive document ...
Read more

Patent EP2873423A2 - Soluble hiv-1 envelope glycoprotein ...

The foregoing applications, and all documents cited therein or during their prosecution ("appln cited documents") and all documents cited or referenced in ...
Read more